Skip to main content

Project

Performed biosimilars landscape study for a leading generics company to assess risks to growth projections

Read Time
2 minute read

Situation

  • Biosimilars were one of the main growth opportunities for a major generics player
  • Given its leading position in several areas, the client needed to understand the outlook of the competitive landscape for their future product launches

Solution

  • Analyzed competitive landscape per product group and assessed capabilities of competitors
  • Assessed the key success factors in terms of opportunity generation, manufacturing and route to market
  • Performed risk assessment in the market dynamics in terms of regulators, originator response and pricing

Impact

  • The assessment supported the generics player in better assessing the risks in their growth projections as well as to prioritize those markets where they would be best positioned to expand their position